Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Pro Medicus Limited ( (AU:PME) ) has issued an update.
Pro Medicus Limited reported a robust financial performance for the half-year ended 31 December 2024, with a significant 42.7% increase in after-tax profit to $51.74 million. The company saw a substantial rise in revenue, driven by major contract implementations and expansions in North America, including new agreements with Lurie Children’s Hospital and Trinity Health, which are expected to enhance its market positioning and operational capabilities.
More about Pro Medicus Limited
Pro Medicus Limited operates within the healthcare industry, primarily offering advanced imaging software solutions. The company focuses on expanding its market presence in North America, providing services to hospitals and healthcare institutions.
YTD Price Performance: 12.77%
Average Trading Volume: 343
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $18.78B
For detailed information about PME stock, go to TipRanks’ Stock Analysis page.
